Moreover, the observed increase of CB2 and TRPV1 protein expression levels let us suppose that these receptors could also be interesting remarkable targets to suppress the altered inflammatory state and potentially to counteract inflammatory-related pain in SCD patients. Here, TRPV1 is linked to Schnyder corneal dystrophy.